Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
Unrelated hematopoietic stem cell donors as research subjects
Unrelated hematopoietic stem cell donors as research subjects
Regulation of donor participation in research studies: is there another way?
Enshrining donor rights and optimizing patient outcome in unrelated donor transplantation
Reduced-intensity SCT for chronic active EBV infection: excellent outcomes should trigger future investigations on how EBV-positive recipient cells are eradicated
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data
Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen
Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries
Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT
Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita
Feasibility of BU, CY and etoposide (BUCYE), and auto-SCT in patients with newly diagnosed primary CNS lymphoma: a single-center experience
Auto-SCT induces a phenotypic shift from CMP to GMP progenitors, reduces clonogenic potential and enhances in vitro and in vivo cycling activity defined by 18F-FLT PET scanning
Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT
Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study
Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program
Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective
Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis
Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome
H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT
Black hole in the lung
Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma
Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD
Long-term outcome of patients with monoclonal Ig deposition disease